Clinical Trials Browser

NCT04105270 2025-09-11

RMT in Combination With Durvalumab + Chemo in Untreated Adenocarcinoma NSCLC. A Randomized Double Blind Phase II Trial

Phase 2 Recruiting

82 enrolled

Thoracic

Adenocarcinoma of Lung, Lung Neoplasms

NCT04942730 2024-05-07

FluBuBe

Phase 2 Completed

50 enrolled

LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03549650 2022-03-04

Prevention and Management of Intravesical BCG-related Lower Urinary Tract Symptoms

Phase 2 Terminated

3 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Lower Urinary Tract Symptoms

NCT02756663 2016-11-08

PANORAMA-5

Phase 2 Withdrawn

Plasma cell

Multiple Myeloma, Recurrence

NCT00698516 2012-03-27

Study of Oral Topotecan With Bevacizumab for Recurrent Small Cell Lung Cancer

Phase 2 Completed

50 enrolled 13 charts

Thoracic

Small Cell Lung Carcinoma